1. Introduction {#sec1}
===============

As the nation\'s population ages, the volume of surgical interventions on older patients has continued to grow. The United States census data has shown that from 1980 to 2010, the age of citizens 65--89 years old has doubled, and those greater than 90 years old has almost tripled \[[@bib1]\]. This increase in life expectancy presents the challenge of continuing to deliver safe and effective health care to not only the elderly, but those with a significant number of medical comorbidities \[[@bib2]\]. These patients often require complex medical and surgical decision making to achieve the most successful outcomes and to maintain a functional quality of life.

Open colorectal surgery in the elderly has been associated with increased morbidity and mortality when compared with younger patients \[[@bib3],[@bib4]\]. With a decreased physiologic reserve and an increased number of comorbidities, the application of laparoscopy has become particularly important to this population. This technique is associated with a decreased length of stay (LOS), decreased morbidity rate, earlier return of bowel function, and equivalent oncologic outcomes as compared to open surgery for patients greater than 70 years old \[[@bib5], [@bib6], [@bib7], [@bib8]\]. Laparoscopic rectal surgery, however, has a steeper learning curve as compared to a laparoscopic colectomy due to the complex anatomical nature of the pelvis, and relatively poor ergonomics of laparoscopic instruments \[[@bib9]\]. Furthermore, laparoscopic proctectomy is associated with a greater rate of conversion to an open procedure, which may subsequently lead to long-term complications. In addition, studies have demonstrated an increased risk of bladder and sexual dysfunction when compared to an open approach \[[@bib10],[@bib11]\].

The da Vinci surgical system (da Vinci Surgical System; Intuitive Surgical Inc.) was approved by the US Food and Drug Administration in 2000 as a robotic surgical device. This operating system was designed in an effort to help minimize the learning curve experienced by many surgeons when transitioning to a minimally invasive approach. This platform was created to improve visualization and stability, increase the freedom of movement, and maximize dexterity \[[@bib12]\]. Because these features eliminate many of the technical limitations of laparoscopy, robotic operations have been proposed to bridge the gap between open and laparoscopic surgery, thus facilitating the dispersion of minimally invasive techniques to a broader population. Some data on robotic proctectomy has shown the robotic approach to decrease LOS, postoperative complications, conversion rates, and circumferential margin involvement when compared to traditional laparoscopy \[[@bib13], [@bib14], [@bib15], [@bib16]\]. However data from the highly anticipated ROLARR (Robotic versus Laparoscopic Resection for Rectal Cancer) trial showed no benefit to robotic surgery in reducing the conversion to open in curative resection for rectal adenocarcinoma. It did show that laparoscopic and robotic assisted laparoscopic were equivalent as far as outcomes studied \[[@bib17]\]. Although the use of a minimally invasive technique appears to be especially beneficial for the elderly population, there is a paucity of literature describing robotic proctectomy for this cohort \[[@bib16]\]. Therefore, we aimed to evaluate both the trend in utilization and surgical outcomes following robotic proctectomy for rectal cancer among patients ages 70 years or greater in the United States.

2. Materials and methods {#sec2}
========================

The Human Use Committee approved the study protocol. This work has been reported in line with the STROCSS criteria; it has been registered with [ClinicalTrials.gov](http://ClinicalTrials.gov){#intref0010}, identification number NCT03765411 \[[@bib18]\]. Investigators adhered to the policies for protection of human subjects as prescribed in 45 Code of Federal Regulation 46. The Nationwide Inpatient Sample (NIS) database is the largest all-payer inpatient care database in the United States including persons covered by Medicare, Medicaid, private insurance and the uninsured, with data from over 8 million hospital admissions each year. This dataset allows for accurate national estimates from approximately 20% of all discharges nationwide. It includes admission and discharge diagnoses, procedures performed and complications and outcome data during the hospitalization \[[@bib19]\]. Data was collected from the NIS, a part of the Health Care Utilization Project (HCUP), Association for Healthcare Research and Quality (AHRQ) from 2006 to 2013.

2.1. Definition of variables {#sec2.1}
----------------------------

Patients 70 years of age or older were identified by primary *ICD-*9-CM procedure codes for proctectomy (48.62, 48.63, 48.64, 48.69). We excluded all emergent admissions (NIS ELECTIVE ≠ 1) and those patients undergoing abdominoperineal resections (48). Patients were categorized by *ICD-*9-CM procedure codes for operative approach: robotic (48.62, 48.63, 48.64, 48.69 + 17.41, 17.42, or 17.49), laparoscopic (48.62, 48.63, 48.64, 48.69 + 54.21), and open (48.62, 48.63, 48.64, 48.69). Conversion from laparoscopic or robotic to open was documented. All cases were restricted to patients with an *ICD-*9-CM diagnosis code for rectal cancer (154.0, 154.1, 153.9, 198.8) ([Table 1](#tbl1){ref-type="table"}). Trends in utilization of each approach were determined, and in-hospital outcomes were compared between the minimally invasive cohorts and an open approach. All variables and outcomes with a sample size less than 10 were excluded per NIS guidelines.Table 1Procedure codes and operative group designator Code(s).Table 1ProcedureICD-9-CM Procedure CodeAnterior resection of the rectum with synchronous colostomy48.62Anterior resection of the rectum, other48.63Posterior resection of the rectum48.64Resection of the rectum, other48.69  Operative ApproachDesignator ICD-9-CM Procedure CodesOpenNo additional codesLaparoscopic54.21Robotic17.42 (Laparoscopic robotic assisted)17.49 (Other/unspecified robotic assisted)

2.2. Demographics {#sec2.2}
-----------------

Demographic data collected by NIS includes: age, gender, race, disease stage, household income zip code quartile, obesity (yes or no), hospital bed side (small, medium, large), days from admission to procedure, comorbidities, disposition (home, short-term hospital, home health care, against medical advice, died in hospital, discharged alive destination unknown), insurance status, geographic region, and teaching status/location of the hospital (urban versus rural).

2.3. Comorbidities {#sec2.3}
------------------

Comorbidities identified included: arthritis, congestive heart failure, chronic obstructive pulmonary disease, coagulopathy, diabetes with or without chronic complications, hypertension, liver disease, metastatic cancer, morbid obesity, non-morbid obesity, peripheral vascular disease, pulmonary circulation disease, renal failure, solid tumor without metastases, and weight loss. In addition, comorbidities were assessed using the Elixhauser Comorbidity index (ECI). The ECI is based on the Charlson comorbidity index, which predicts the one year mortality for patients with certain conditions \[[@bib20]\]. Unlike the Charlson Comorbidity index, which includes 17 comorbidities, the ECI includes 30 variables. The Elixhauser Index is a combination of these 30 comorbidities, identified via *ICD-*9-CM codes, but excludes the diagnosis related group (DRG) \[[@bib21]\].

The All Patient Refined Disease Related Group (APR-DRG) (3 M™ Health Information Systems) is a measure to compare a patient\'s risk of mortality (ROM) and severity of illness (SOI). DRG correlates with the patient\'s main diagnosis but is categorized into specific diagnoses that can be compared across cohorts. The APR-DRG was developed from the Medicare/Medicaid DRG prospective payment system to provide a risk-adjustment tool, garnered from clinical models based on historical data. Categories utilized to determine this score include age, type of surgical procedure, comorbidities, and the principle diagnosis. A SOI and ROM score is assigned to each surgical procedure and is indicated as minor \[[@bib1]\], moderate \[[@bib2]\], major \[[@bib3]\], or extreme \[[@bib4]\]. The software is proprietary, however, the methodology used to determine this score has been validated and used as a mean of risk-adjustment in previous studies \[[@bib22], [@bib23], [@bib24], [@bib25]\].

2.4. Age {#sec2.4}
--------

Age was analyzed as a continuous variable for all comparisons. Cases were separated into five groups: 70--74, 75--79, 80--84, 85--89, and 90 years of age and older.

2.5. Race {#sec2.5}
---------

Race was defined at Caucasian, African American, Hispanic, other, and unknown. Patients for whom data was unavailable were classified into unknown.

2.6. Insurance status {#sec2.6}
---------------------

Patients were categorized by insurance status: Medicare, Medicaid, or private insurance. Patients who did not have any form of insurance (i.e. self-pay) were grouped together as "other."

2.7. Disease stage {#sec2.7}
------------------

Disease stage was divided into localized, locally advanced, regionally nodal, and metastatic. These categories were further divided by HCUP and AHRQ criteria based on size and spread of disease.

2.8. In-hospital complications {#sec2.8}
------------------------------

Complications were analyzed by system and included: mechanical wound, infections, urinary, pulmonary, gastrointestinal, cardiovascular, systemic, surgical, and any complication. Specific complications were also evaluated and included: acute kidney injury, cardiac arrest, deep venous thrombosis, myocardial infarction, pneumonia, pulmonary embolism, sepsis/septic shock, stroke, surgical sight infection, postoperative intubation, and urinary tract infection.

2.9. Ostomy creation {#sec2.9}
--------------------

Ostomy creation was evaluated. Patients who underwent ostomy creation were separated into ileostomy and colostomy.

2.10. In-hospital mortality {#sec2.10}
---------------------------

In-hospital mortality was evaluated as a secondary outcome measure. Data for patients collected by NIS is only available until discharge. Therefore, any death within 30 days of a procedure, but after discharge, was not available.

2.11. Length of stay {#sec2.11}
--------------------

Length of stay was measured in days. The median and interquartile range (IQR) were compared between groups.

2.12. Costs and charges {#sec2.12}
-----------------------

Hospital charges refer to the total amount billed by the hospital. Hospital cost refers to the amount paid by the insurance provider. Medians (IQR) were compared between groups.

2.13. Statistical analysis {#sec2.13}
--------------------------

All statistical analyses were performed using SAS software version 9.2 (SAS Institute, Cary, NC). Unless otherwise noted, results are presented as unadjusted frequencies and a weighted percent because the NIS database is a 20% sample of yearly inpatient admission. To account for the complex sampling design of NIS, SAS SURVEYFREQ and SURVEYLOGISTIC statistical procedures with subdomain analysis were used to analyze categorical dependent variables. SURVEYMEANS and SURVEYREG were used for continuous dependent variables, per guidance of Healthcare Cost and Utilization Project NIS tutorials. The percent of missing data was less than 1% for all variables except race (15%), disease stage (33%), days from admission to procedure (10%) and household income (2%). Missing data for race and income were classified as "unknown" for analysis.

Chi-square tests and t-tests were used to compare demographics and outcomes between the robotic group and the laparoscopic and open groups. Multivariable logistic regression was used for adjusted analyses of complications. Because patients were not randomly assigned to surgical procedures, a propensity model was developed to address potential selection bias. This model was used to predict the estimated propensity for undergoing a robotic procedure versus a lap or open procedure based on demographic data, diagnosis, and hospital characteristics for the intended operation. The estimated propensity score from this model was added into the adjusted models as a predictor for the outcome variables. Total hospital charges and LOS were also compared. A stepwise approach based on a significance level of p \< 0.05 was adopted for including variables in a final adjusted model. Age, sex, and the ECI were forced into the adjusted analyses regardless of significance as these were felt to be clinically significant. Adjusted odds ratios (ORs) are reported with 95% confidence intervals (CIs) or Interquartile Ranges (IQR). Variables with multiple categories are reported with OR referenced to the first category. A significance level p \< 0.05 was used for all analyses.

3. Results {#sec3}
==========

3.1. Demographics {#sec3.1}
-----------------

We identified 6740 admissions for patients receiving a proctectomy for rectal cancer. The operative approach included 5879 open, 666 laparoscopic, and 195 robotic procedures. The median age was 77 years old (IQR 73--82), 54% of cases were men, and 3% of patients were greater than 90 years old. Utilization of both laparoscopic (1% median change in weighted percent over 7 years, IQR 0--3%) and robotic (8.5% median change in weighted percent over 7 years, IQR 8--11%) approaches increased significantly when compared to an open procedure (−1% median change in weighted percent over 7 years, IQR -2 - 0%) over the time course of this study (p \< 0.01). The overall rate of open proctectomy decreased from 1039 to 740 cases, a reduction in weighted percent from 15% to 11% (please see the methods section for further explanation of NIS weighted percent). The open approach declined from 16% to 10%, and the laparoscopic approach increased from 9% to 16% over time. The utilization of the robotic platform increased from zero reported cases in 2006 to 75 in 2013 ([Table 2](#tbl2){ref-type="table"}; [Fig. 1](#fig1){ref-type="fig"}).Table 2Demographics.Table 2All (n = 6740) n (weighted %)Open (n = 5879) n (weighted %)Robotic (n = 195) n (weighted %)Laparoscopic (n = 666) n (weighted %)p-valueOpen vs. RoboticLap vs. RoboticAge 70-742238 (33)1920 (33)87 (45)231 (35)**\< 0.01**0.109 75-792001 (30)1753 (30)52 (27)196 (29) 80-841507 (22)1315 (22)37 (19)155 (23) 85-89775 (12)688 (12)\*72 (11) 90+219 (3)203 (3)\*12 (2) median (IQR)77 (73--82)77 (73--82)75 (72--80)77 (72--81)**\<0.010.01**Gender Male3634 (54)3139 (54)105 (54)390 (59)0.9170.247 Female3099 (46)2733 (46)90 (46)276 (41)Race/ethnicity White4654 (69)4061 (69)133 (68)460 (69)**0.02**0.841 Black314 (5)275 (5)\*30 (4) Hispanic389 (6)319 (5)17 (9)53 (8) Other373 (5)307 (5)18 (9)48 (7) Unknown1010 (15)917 (16)18 (9)75 (11)Region Northeast1437 (22)1259 (22)37 (19)141 (21)0.8840.524 Midwest1517 (23)1320 (23)49 (25)148 (22) South2487 (37)2194 (37)74 (37)219 (33) West1299 (19)1106 (18)35 (18)158 (23)Medicare No552 (8)461 (8)22 (11)69 (10)0.0930.682 Yes6183 (92)5414 (92)173 (89)596 (90)Location/teaching status Rural10 (678)11 (634)\*42 (6)**\<0.01\<0.01** Urban non-teaching43 (2878)43 (2536)57 (30)285 (43) Urban teaching47 (3165)46 (2697)134 (69)334 (51)Hospital bed size Small11 (754)11 (672)19 (9)63 (9)0.8270.919 Medium25 (1635)25 (1424)45 (24)166 (25) Large65 (4332)64 (3771)129 (67)432 (66)Disposition Routine50 (3330)50 (2864)98 (52)368 (56)**\<0.010.01** Home Health Care26 (1721)26 (1488)68 (36)165 (25) Transfer23 (1539)24 (1397)24 (13)118 (18)Disease Stage Localized68 (3096)68 (2788)30 (89)278 (71)0.0630.152 Locally advanced4 (172)4 (155)\*17 (4) Regionally nodal15 (700)16 (644)\*52 (13) Metastatic12 (562)13 (517)\*44 (11)Elixhauser mean (std)6.66.75.25.9**0.02**0.31 median (IQR)3.4 (−1.1--11.6)3.8 (−1.1--11.6)−0.1 (−1.3--11.3)2.4 (−1.2--11.3)[^1]Fig. 1The above figure shows the annual number of proctectomy cases (procedure codes defined in [Table 1](#tbl1){ref-type="table"}), separated by operative approach.Fig. 1

3.2. Comorbidities {#sec3.2}
------------------

The mean Elixhauser Comorbidity Index was significantly greater in the open vs. robotic cohort (6.7 CI 6.5--6.9 vs. 5.2 CI 4--6.3; p = 0.02), with no significant difference when comparing the robotic to laparoscopic groups. The APR-DRG risk of mortality and severity scores differed between all three groups: weighted mean open 53.75 and 55.75, weighted mean laparoscopic 50.25 and 53, and weighted mean robotic 44.5 and 46.75 respectively. The open group had the greatest risk of mortality when compared to the laparoscopic and robotic cohorts (Open CI 53--54, Laparoscopic CI 48--52, and Robotic CI 41--48; p \< 0.01).

3.3. Outcomes {#sec3.3}
-------------

The rate of a complication following proctectomy was 22% (all approaches combined), with the majority of complications related to the gastrointestinal system (9.4%). A robotic approach was associated with a significantly reduced risk of total complications when compared to an open (13% vs. 23%; p \< 0.01) and laparoscopic (21% vs. 13%; p = 0.01) approach. There was no significant difference in the risk of total complications following multivariate analysis (robotic versus open: OR 0.66 CI 0.4--1, p = 0.06; robotic versus laparoscopic: OR 0.66 CI 0.4--1, p = 0.09). The mortality rate was low (2.1%) with no significant difference among the groups (p = 0.9 for both comparisons). All remaining outcome measures evaluated had a sample size less than ten and therefore could not be statistically compared due to NIS database guidelines. Median (IQR) LOS was shorter in the robotic cohort at 4.3 (3--7) days, compared to the laparoscopic \[5.8 (4--8)\] and open \[6.7 (5--10)\] groups (p \< 0.01).

3.4. Costs and charges {#sec3.4}
----------------------

The median (IQR) total hospital charges were greater in the robotic group \$64,743 (\$44,731-\$98,397) compared to laparoscopic \$55,813 (\$38,402-\$82,069) and open groups \$50,355 (\$33,376-\$81,231) (p \< 0.01). The variation in cost between different surgical approaches was significantly less than the differences in charges between different surgical approaches. However, there was still a significant difference in cost noted between groups. Findings demonstrated the median (IQR) cost for a robotic procedure to be \$18,889 (\$15,179-\$26,599), a laparoscopic procedure \$21,270 (\$12,491-\$24,380), and an open procedure \$16,134 (\$11,712-\$24,146) (p \< 0.01) ([Table 3](#tbl3){ref-type="table"}).Table 3Comorbidities by Operative Approach (in weighted percentage). Bolded p values are statistically significant.Table 3ComorbidityAllOpenRoboticLaparoscopicp-valueOpen vs. RoboticLap vs. RoboticArthritis1.51.41.02.00.580.33CHF10.010.54.57.5***0.01***0.13Chronic pulmonary disease18.018.413.416.10.060.35Coagulapathy2.93.03.22.50.880.61Diabetes with chronic complications2.32.40.52.60.080.07Hypertension66.065.865.967.70.990.62Liver disease1.11.10.52.00.470.17Metastatic cancer25.926.415.324.8***\<0.01**0.01***Obesity6.66.36.29.10.970.21Peripheral vascular disease6.46.55.96.00.740.99Pulmonary circulation disease2.02.02.02.00.981.00Renal failure7.37.37.66.60.880.61Solid tumor w/o metastasis4.14.23.52.60.640.50Weight loss7.17.28.25.60.610.20Diabetes (with or without complications)24.024.322.022.10.460.98COPD13.814.310.610.60.140.99Morbid obesity1.71.71.62.20.900.62Nonmorbid obesity5.14.85.77.60.560.37  Elixhauser mean (std)6.66.75.25.9***0.02***0.31 median (IQR)3.4 (−1.1--11.6)3.8 (−1.1--11.6)−0.1 (−1.3--11.3)2.4 (−1.2--11.3)

4. Discussion {#sec4}
=============

As technology progresses it is critical that surgeons continue to build their armamentarium of techniques in efforts to provide the most safe and effective care to all patients. These results have demonstrated an increased trend in the utilization of the robotic platform, with findings that are consistent with the current literature. Damle et al. identified a 17% increase in robotic assisted colorectal surgery (RACS) between 2011 and 2015 while Lee et al. demonstrated a 41-fold increase in the robotic treatment of colorectal cancer between 2004 and 2012 \[[@bib26],[@bib27]\]. Halabi *et al* found a similar increase when looking at colorectal surgery in the United States and noted that while RACS is increasing in all hospital settings, it is being implemented at a greater rate in urban teaching centers \[[@bib28]\]. The rise in the utilization of robotic surgery has been attributed to a myriad of factors. The appeal of the improved ergonomics seems to play a role but is difficult to validate \[[@bib29]\]. Industry involvement with academic centers in the implementation of this device among training centers throughout the country, combined with the centralization of medical care, propels patients towards high volume large budget centers \[[@bib26],[@bib30], [@bib31], [@bib32]\]. Patients themselves are contributing towards this trend as hospitals, and hospital systems, compete to maintain minimum procedure volumes. This process is occurring despite a lack of objective data on the quality differences in care \[[@bib33], [@bib34], [@bib35]\]. Despite an overall shorter length of stay, robotic surgical patients had a significantly greater median hospital charge when compared to the laparoscopic or open approach. The similarity in cost between the groups is likely in part due to the shorter length of stay as well as the potential reduction in postoperative complications in the robotic group.

The overall reduction in postoperative morbidity and mortality in laparoscopic compared to open colorectal surgery in the elderly has been well documented \[[@bib16],[@bib36],[@bib37]\]. In contrast, most studies comparing short-term outcomes between laparoscopic and robotic proctectomy have not shown a significant difference in complication rate between the two groups \[[@bib38], [@bib39], [@bib40], [@bib41]\]. While there appeared to be a potential trend towards decreased complications with the robotic group, we are unable to make a full assessment due to the sample size. As additional year groups are released by the NIS, further investigations may be performed using an adequately powered dataset to further elucidate these trends in improved outcomes with a robotic operation.

A significantly shorter LOS was seen in following a robotic operation compared to the laparoscopic and open procedures. Multiple meta-analyses comparing laparoscopic and open colorectal resection in the elderly have shown a reduced length of stay in patients undergoing a minimally invasive approach \[[@bib37],[@bib42]\]. Conversely, previous studies have demonstrated an equivalent length of stay between a robotic and a laparoscopic resection for rectal cancers \[[@bib28],[@bib38], [@bib39], [@bib40], [@bib41],[@bib43]\]. However, the mean age reported in these studies was 55--65 years old, a cohort significantly younger than those presented here. A recent study published in the Journal of Robotic Surgery shows similar operative times between laparoscopic and robotic approaches in colon and rectal resection. Furthermore, it has been shown in some series that operative and oncologic outcomes are similar between the two approaches in those 70 years of age and older. This was shown to be the case even with longer operative times in elderly patients compared with younger patients (300.6 min versus 214.5 min p = 0.03). The reason for the longer operative times was not fully explained although it does raise concern for the possibility of inappropriate matching in one particular study \[[@bib44],[@bib45]\]. The aggregate of this data does point towards if not a benefit of robotic assisted surgery, then at least an equivalency in a myriad of age groups. Hence with the data shown here, the reduction in length of stay identified in the robotic group may act as a surrogate marker for an overall improvement in postoperative outcomes.

The discussion of costs and charges in regards to the robotic approach is not a new one. Other published data show the robotic approach total hospitalization cost to be 131% of the cost of the open approach. The data presented here shows the robotic approach to be 117% of the cost of an open approach hospitalization. As mentioned in the results section, the difference in charges appears to be more robust than the difference in cost \[[@bib46]\]. It is not clear from this data why that is but it does warrant further monitoring to see if the difference diminishes with time.

We do acknowledge that there are inherent limitations in the utilization of the Nationwide Inpatient Sample. First, this is a retrospective study, and these results only demonstrate an association between findings. The NIS is an administrative database, and therefore has the potential for data entry error and missing data. Due to the design of this database, we are limited by the type and number of complications that could be evaluated, and there is no means of collecting long-term data following hospital discharge. Comorbidities and complications may also be under-coded when utilizing the *ICD-*9-CM system to collect data when compared to a clinical dataset such as NSQIP. Furthermore, there is an inherent selection bias among the pooled data from each institution, as well as variability among surgeon skill level and experience which cannot be accounted for in this database. In addition, implementation of robotic proctectomy in the elderly population is still in its infancy, as evidenced by only 75 reported cases in the databanks most recent year group (2013). This results in an underpowered sample size, limiting the potential data analysis and conclusions that could be ascertained. This study is unable to evaluate both the short and long-term oncologic outcomes, including resection margins and lymph node yield, findings which are critical to rectal cancer care. Despite these limitations, this study demonstrates the increasing adoption of robotic proctectomy for elderly individuals with similar and potentially improved postoperative outcomes when compared to a laparoscopic and an open approach.

5. Conclusion {#sec5}
=============

Robotic proctectomy is growing in popularity. This, in concert with an ageing American population, necessitates further studies of the potential risks and benefits of this procedure. These results represent the largest analysis of robotic proctectomy in this population, and support the safety and efficacy of this approach in the elderly. This study provides a foundation for further investigations to fully elucidate the benefit of this operation in the treatment of rectal cancer.
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==============================

The following is the Supplementary data to this article:Multimedia component 1Multimedia component 1Multimedia component 2Multimedia component 2

Supplementary data to this article can be found online at <https://doi.org/10.1016/j.amsu.2019.06.004>.

[^1]: \* indicates sample size less than 10. Bolded p values are statistically significant.
